Weight Loss Surgeon
Semaglutide and vision loss
The hidden dangers of weight loss drugs: New study links Ozempic to vision loss
In the pursuit of rapid weight loss, many adults have turned to GLP-1 medications like Ozempic, Wegovy, and Mounjaro. However, a shocking new study published in JAMA Ophthalmology has raised serious concerns about their unexpected effects on eye health. Experts warn that these medications may be linked to three potentially blinding eye conditions, including non-arteritic anterior ischemic optic neuropathy (NAION), a type of eye stroke that can cause sudden and irreversible vision loss.
The eye-opening study
The study examined reports from nine individuals—five women and four men—with an average age of 58 who were taking semaglutide (the active ingredient in Ozempic and Wegovy) or tirzepatide (found in Mounjaro and Zepbound). Seven of these patients developed NAION, while one experienced a retinal stroke, and another suffered from swelling in both optic nerves.
According to lead researcher Dr. Bradley Katz, an ophthalmologist at the John A. Moran Eye Center and professor at the University of Utah, “This stroke causes irreversible loss of vision in one eye.” While one patient developed swelling without losing vision, the findings raise alarms about the risks associated with these medications.
How can Ozempic affect vision?
Experts suggest that the rapid drop in blood sugar levels caused by these weight loss drugs could be responsible for the damage. “These drugs are very effective at reducing blood sugar, and when it happens too quickly, it can cause swelling in the optic nerve,” Dr. Katz explained. This phenomenon, known as an osmotic shift, occurs when fluid shifts between blood vessels and cells due to a sudden change in sugar concentration.
Additionally, diabetic eye conditions, such as diabetic retinopathy, could be worsened by these medications. Diabetic retinopathy occurs when high blood sugar damages the retina’s blood vessels, leading to swelling, bleeding, and even retinal detachment in severe cases.
Semaglutide’s impact on eye health
Other risks associated with Ozempic
- Thyroid tumors
- Pancreatitis
- Hypoglycemia (low blood sugar)
- Gallbladder disease
- Kidney failure
- Increased cancer risk
What should patients do?
While these findings are concerning, experts emphasize that vision loss remains a rare side effect. However, individuals taking these medications—especially those with pre-existing diabetes or eye conditions—should undergo regular eye exams and monitor for any changes in vision. If you experience sudden vision loss, blurry vision, or eye pain, seek immediate medical attention.
As weight loss drugs continue to rise in popularity, ongoing research will be crucial in understanding their full impact on eye health and beyond. In the meantime, patients should consult their healthcare providers to weigh the benefits and risks before starting GLP-1 medications.
References
Related
-
How to Stay Healthy during the festive season. Tips for weight loss surgery patients
The holidays may be the happiest and most exciting time of year, but they can also be the...
-
The Weight Loss Surgery Journey: A Test of Patience
This gastric sleeve patient lost nearly half of his body weight, and is now a svelte 143 pounds...
-
Gastric Banding: An Effective Solution to Shed Those Extra Inches
Obesity is one of the fastest growing health concerns in Australia, with nearly half of the country’s adult...
